Skip to main content
. Author manuscript; available in PMC: 2018 Apr 9.
Published in final edited form as: J Matern Fetal Neonatal Med. 2014 Jan 6;27(10):975–983. doi: 10.3109/14767058.2013.847918

Figure 1.

Figure 1

Amniotic fluid secreted phospholipase A2 concentrations (sPLA2) in women at term with clear amniotic fluid and MSAF. Patients with MSAF had a significantly higher median amniotic fluid secreted phospholipase A2 concentration (ng/mL) than those with clear amniotic fluid [1.7 (1–2.9) versus 0.3 (0–0.6); p < 0.001].